We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Cuts Diagnostic Delays in Prostate Cancer

By HospiMedica International staff writers
Posted on 06 Aug 2025

Accurately identifying the extent of prostate cancer is critical to treatment planning, but remains a significant challenge in oncology. More...

Traditional diagnostic methods often result in underestimation of cancer margins, leading to suboptimal interventions. Physicians face difficulty in precisely outlining cancer margins while minimizing damage to non-cancerous tissue. This limitation affects the efficacy of treatments such as focal therapy and may compromise patient outcomes. Now, a new study has demonstrated that using artificial intelligence (AI) significantly improves physicians’ ability to define prostate cancer margins, enhancing diagnostic precision and minimizing misidentification of cancer extent. By analyzing a patient’s MRI data, fusion biopsy, pathology, and biomarkers, AI identifies subtle patterns and indicators of cancerous tissues that are often undetectable in traditional imaging methods.

The study found that Avenda Health’s (Culver City, CA, USA) AI-powered cancer mapping technology called Unfold AI improved the abilities of urologists and radiologists in identifying cancer extent by 45x. In a multi-reader, multi-case study involving seven urologists and three radiologists from five institutions, researchers tested the performance of Unfold AI in comparison to traditional cognitive and hemi-gland cancer margin assessments. Each physician evaluated 50 prostate cancer cases by first defining cancer margins manually, then repeating the task after a four-week interval using the AI-assisted software. The study aimed to evaluate how well Unfold AI could support clinicians in delineating cancer boundaries with accuracy while reducing the inclusion of healthy tissue.

The findings, published in The Journal of Urology, showed that AI-assisted cancer margins achieved a balanced accuracy of 84.7 percent, outperforming cognitively-defined (67.2 percent) and hemi-gland (75.9 percent) approaches. Unfold AI also significantly reduced the underestimation of cancer extent, with a negative margin rate of 72.8 percent compared to just 1.6 percent for cognitively-defined margins. These results suggest that integrating AI tools like Unfold AI into clinical workflows can lead to more precise and effective treatment strategies, ultimately improving patient care. The technology’s recognition by the American Medical Association as a Category III CPT code further signals its potential for widespread adoption. Future plans include expanding the use of Unfold AI to support physicians in delivering more personalized and data-driven prostate cancer interventions.

"This study is important because it shows the ability of AI to not only replicate expert physicians, but to go beyond human ability. By increasing the accuracy of cancer identification in the prostate, more precise and effective treatment methods can be prescribed for patients," said Dr. Wayne G. Brisbane, MD, co-author and physician researcher involved in the study.

Related Links:
Avenda Health 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.